Hamza Celik
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 17
- Acute Myeloid Leukemia Research 15
- Chronic Myeloid Leukemia Treatments 4
- Hematopoietic Stem Cell Transplantation 2
- Genetics 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Co-authors
- Grant Anthony Challen (17 shared papers)Ashley C. Kramer (7 shared papers)Andrew Martens (5 shared papers)Cates Mallaney (10 shared papers)Elizabeth L. Ostrander (9 shared papers)Blanca Rodríguez (2 shared papers)Mira Jeong (2 shared papers)Margaret A. Goodell (2 shared papers)
- Journals
- Blood (6 papers)Leukemia (2 papers)Experimental Hematology (2 papers)Blood Advances (1 paper)International Journal of Hematology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Hamza Celik
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 68
- Hematology 439
- Genetics 192
- Aging 26
- Molecular Biology 794
- Cancer Research 109
Countries citing papers authored by Hamza Celik
This map shows the geographic impact of Hamza Celik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamza Celik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamza Celik more than expected).
Fields of papers citing papers by Hamza Celik
This network shows the impact of papers produced by Hamza Celik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamza Celik. The network helps show where Hamza Celik may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamza Celik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 283 | |
| 2 | 2016 | 221 | |
| 3 | 2018 | 181 | |
| 4 | 2014 | 82 | |
| 5 | 2019 | 47 | |
| 6 | 2018 | 46 | |
| 7 | 2017 | 43 | |
| 8 | 2021 | 34 | |
| 9 | 2022 | 32 | |
| 10 | 2016 | 29 | |
| 11 | 2022 | 27 | |
| 12 | 2022 | 18 | |
| 13 | 2024 | 18 | |
| 14 | 2021 | 14 | |
| 15 | 2014 | 2 | |
| 16 | 2016 | 2 | |
| 17 | 2021 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2024 | 1 |
About Hamza Celik
Hamza Celik is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Cancer Research, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Epigenetics and DNA Methylation (9 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer Genomics and Diagnostics (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Kruppel-like factors research (2 papers). The work is most often cited by research in Hematology (439 citations), Genetics (192 citations), Aging (26 citations), Molecular Biology (794 citations) and Cancer Research (109 citations). Hamza Celik has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Grant Anthony Challen, Ashley C. Kramer, Andrew Martens, Cates Mallaney, Elizabeth L. Ostrander, Blanca Rodríguez, Mira Jeong, Margaret A. Goodell, John R. Edwards and James I. McDonald. Their work appears in journals such as Blood, Leukemia, Experimental Hematology, Blood Advances and International Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.